Results 221 to 230 of about 12,196 (247)

Levodopa and Decarboxylase Inhibitors

Drugs, 2012
R M Pinder, R N Brogden, Phyllis R Sawyer   +2 more
exaly  

Levodopa, vitamins, ageing and the neuropathy of Parkinson’s disease

Journal of Neurology, 2013
Yusuf A Rajabally
exaly  

Levodopa unresponsive symptoms in Parkinson disease

Movement Disorders, 2008
Kapil Sethi
exaly  

Levodopa responsiveness of dysphagia in advanced Parkinson's disease and reliability testing of the FEES-Levodopa-test

Parkinsonism and Related Disorders, 2016
Tobias Warnecke, Jens B Schröder, Nani Osada   +2 more
exaly  

Effect of levodopa‐carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients

Movement Disorders, 2016
Angelo Antonini, VÍCTOR S C Fung, James T Boyd   +2 more
exaly  

Relationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weight

European Journal of Neurology, 2008
J C Sharma, Olivier Rascol
exaly  

Comparison of pharmacokinetic profile of levodopa throughout the day between levodopa/carbidopa/entacapone and levodopa/carbidopa when administered four or five times daily

European Journal of Clinical Pharmacology, 2009
Mikko Kuoppamäki, Valtteri Kaasinen, Päivi Ruokoniemi   +2 more
exaly  

Levodopa see Carbidopa/levodopa

Reactions Weekly, 1991
openaire   +1 more source

Levodopa

Reactions Weekly, 2023
openaire   +1 more source

Levodopa

Reactions Weekly, 2020
openaire   +2 more sources